How long does it take to resume breastfeeding and the safe interval after taking Cabergoline?

Cabergoline (Cabergoline) is a dopamine receptor agonist, mainly used to inhibit prolactin secretion, thereby preventing or terminating lactation. For women who are breastfeeding, prolactin levels in the body will drop rapidly after taking cabergoline, and milk secretion usually decreases significantly or even stops completely within 24 hours to 48 hours after taking the drug. Therefore, if the patient plans to resume breastfeeding, the metabolism of the drug in the body and the recovery of prolactin levels need to be fully considered to ensure the safety of milk production and infant intake.

Normally, the half-life of cabergoline is approximately 65 hours, but the pharmacological effects may last longer. In order to ensure that the drug is almost completely eliminated, it is clinically recommended to wait at least 1 weeks before trying to resume breastfeeding. This can reduce the risk of possible effects of drug residues on the baby. Before resuming breastfeeding, the drug concentration in breast milk should be close to zero to ensure safe ingestion by the infant. During this period, the recovery of breast milk secretion can be judged by observing the amount of milk and the sucking condition of the baby.

When resuming breastfeeding, the mother should gradually observe milk secretion and infant intake. If the amount of milk is insufficient or the baby cannot take in nutrients smoothly, you should promptly consult a professional doctor or lactation consultant to determine whether assisted feeding or other measures are needed. At the same time, it is necessary to monitor whether the mother's lactation function has recovered normally and whether there is swelling or pain in the breasts or the risk of infection to ensure the safety of the mother and baby.

In short, it is usually necessary to wait about a week or more after taking cabergoline before breastfeeding can be safely resumed, but the specific time still needs to be determined based on the mother's physical condition, milk recovery, and doctor's advice. During the period of resumption of breastfeeding, the mother should closely monitor the amount of milk and the health of the baby, and gradually resume breastfeeding under professional guidance to ensure that the impact of the drug is minimized and the safety and effectiveness of breastfeeding are maintained.

Reference materials:https://www.drugs.com/